Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR
| Report ID | 250703 |
| Drug Identification Number | 02443449 |
| Brand name | MYLAN-NAPROXEN/ESOMEPRAZOLE MR |
| Common or Proper name | ESOMEPRAZOLE NAPROXEN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE NAPROXEN |
| Strength(s) | 20MG 500MG |
| Dosage form(s) | TABLET (IMMEDIATE AND DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60BT |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-02-27 |
| Actual start date | 2025-02-28 |
| Estimated end date | 2025-04-11 |
| Actual end date | 2025-04-11 |
| Shortage status | Resolved |
| Updated date | 2025-04-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2025-02-19 | English | Compare |
| v2 | 2025-02-19 | French | Compare |
| v3 | 2025-02-21 | English | Compare |
| v4 | 2025-02-25 | English | Compare |
| v5 | 2025-02-25 | French | Compare |
| v6 | 2025-02-28 | English | Compare |
| v7 | 2025-03-03 | English | Compare |
| v8 | 2025-03-03 | French | Compare |
| v9 | 2025-03-31 | English | Compare |
| v10 | 2025-03-31 | French | Compare |
| v11 | 2025-04-09 | English | Compare |
| v12 | 2025-04-09 | French | Compare |
| v13 | 2025-04-15 | English | Compare |
| v14 | 2025-04-15 | French | Compare |
Showing 1 to 14 of 14